You are here: Industry Insights > Consistency Evaluation

News List

Hansoh being the First in Passing the Consistency Evaluation for imatinib mesylate Xiaoyaowan
July 17, 2018
Jiangsu Hansoh Pharmaceutical received the Approval Document on the Drug Supplementary Application for imatinib mesylate issued by SDA...
SDA Issued the 2017 Drug Inspection Report: Many Highlights of this “Answer Sheet” Yuntian
June 26, 2018
The State Drug Administration of China (SDA, formerly (before name change in 2018), CFDA) has issued the 2017 Drug Inspection Report recently (June 8).
A Glimpse of the Latest Developments of the Second Half of Consistency Evaluation through the Top 5 Varieties Xiaoyaowan
April 17, 2018
CFDA has generated 110 acceptance numbers for the generic drug consistency evaluation applications accepted by April 2, 2018, involving 51 varieties of 53 pharmaceutical enterprises.
Jingxin Enters with a Product of Two Specifications: A Sketch of the Rosuvastatin Market in China Xiaoyaowan
March 12, 2018
The Rosuvastatin Calcium Tablets of two specifications (5mg/10mg) of Zhejiang Jingxin Pharmaceutical passed the consiste
Review: Progress of Acceptance Work of Generic Drug Consistency Evaluation in 2017 Erxiao
January 05, 2018
Varieties to be completed the generic drug consistency evaluation be the end of 2018...
Embarrassing Two Different Worlds in Consistency Evaluation: Some about to Win, in the Wrong Track en-cphi.cn
July 07, 2017
With a half of 2017 past, it is only about one and a half year from the time limit for the consistency evaluation of the 289 generic drug varieties in 2018.